GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medlive Technology Co 2192.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

6.59

+0.15%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medlive Technology Co

Its shares trade on HKEX under the ticker 2192.HK. It has been listed since 15 July 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥747.3m and net income of CN¥389.1m. At that date it held total assets of CN¥6.00bn and shareholders' equity of CN¥5.66bn.

Medlive Technology Co., Ltd. operates as an investment holding company, which engages in the provision of precision marketing and corporate solutions, medical knowledge solutions, and intelligent patient management solutions. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
15 Jul 2021
Employees
668
Website
medlive.cn ↗

Leadership

Pay as last reported

  • Ms. Liping TianExecutive Chairwoman of the Board, Chief Executive Officer, since 2013CN¥6.6m
  • Mr. Lijun TianVice President, Deputy Head Of Medical Information Science Research Unit, Executive Director, since 2013CN¥2.2m
  • Ms. Xin ZhouVice President, Executive Director, since 2018CN¥552,000
  • Mr. Jiangtao XinVice President
  • Mr. Liancheng YangVice President
  • Mr. Lixin TianExecutive Director, President - Head of Medical Information Science Research Unit, since 2013CN¥2.4m
  • Ms. Juan LiuAssistant To Chairwoman, Chief Client Officer
  • Mr. Jiang NanMedical Director, Chief Editor Of Content Team, Deputy Head Of Medical Information Science Research Unit
  • Ms. Cheuk Ting ChuJoint Company Secretary
  • Ms. Yanling YangJoint Company Secretary
  • Mr. Kazutaka KanairoNon-Executive Director
  • Mr. Eiji TsuchiyaNon-Executive Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medlive Technology Co Ltd employs 668 full-time employees in Beijing.
  • The company's Precision Marketing segment offers digital detailing and SaaS solutions.
  • Medlive's Medical Knowledge Solutions provide professional medical information services.

Weaknesses

  • The firm operates solely within the domestic market of China.
  • Medlive's business is limited to three segments without international expansion.
  • The company has no international presence beyond China's domestic market.

Opportunities

  • Expanding into international markets could leverage Medlive's SaaS solutions.
  • Growing demand for medical knowledge services in China presents opportunities.
  • Increasing adoption of intelligent patient management solutions in China.

Threats

  • Dependence on China's domestic market exposes Medlive to local economic risks.
  • Competition within China's Health Care sector may intensify.
  • Regulatory changes in China's Health Care industry could impact operations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.